Efficacy of pregabalin in relieving acute postoperative pain- systemic Review & metaanalysis by Dr. A. Vishnuvardhan Reddy et al.
 
Asian Pac. J. Health Sci., 2017; 4(2):93-96                                                e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Reddy et al            ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2017; 4(2):93-96 
www.apjhs.com                                      93 
 
 
Document heading        doi: 10.21276/apjhs.2017.4.2.15                                                                                    Research Article 
 
Efficacy of pregabalin in relieving acute postoperative pain- systemic Review & meta-
analysis 
A. Vishnuvardhan Reddy
1*
, Syed Ali Aasim
2
,Rajendra Prasad
3
, Karthik Satya
3 
1
Assistant Professor, Department Of Anesthesiology,Chalmeda Anandrao Institute Of Medical Sciences, 
Bommakal Village, Karimnagar District, Telangana, India 
2
Professor and HOD Department Of Anesthesiology,Chalmeda Anandrao Institute Of Medical Sciences, 
Bommakal Village, Karimnagar District, Telangana, India 
3
Postgraduate,  Department Of Anesthesiology, Chalmeda Anandrao Institute Of Medical Sciences, 
Bommakal Village, Karimnagar District, Telangana, India 
ABSTRACT 
 
Background: Pregabalin is used for postoperative pain management. Aims and Objectives: To evaluate efficacy of 
pregabalin in relieving acute postoperative pain. Materials and Methods: 650 studies were assessed, out of which 
50 studies with 4012 patients (2212 received pregabalin and 1800 served as control) were included in the final 
analysis. 45 studies investigated acute pain, and 5 chronic pain. Results: Perioperative pregabalin after surgery 
reduced pain scores, hospital stay, opiod side effects. Conclusion: pregabalin has a significant role in relieving acute 
postoperative pain. 
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Introduction 
 
 
Pregabalin, a γ-aminobutyric acid has property of 
reducing the dorsal horn neurones excitability after 
tissue damage. It is usually prescribed for postoperative 
pain management [1,2].Several studies have been 
carried out to evaluate the efficacy of perioperative 
pregabalin  in doses 50 to 300 mg. All the studies 
showed better postoperative analgesia after 
adminstration of pregabalin[3-5].Few studies used 300 
mg of pregabalin and others used in the range of 50–
150, 225–300, and 600–750 mg, but whether effects of 
the drug is due to its dosage or frequency of 
administration is not yet clear. Several studies 
investigated role of perioperative pregabalin in 
relieving acute pain. While few studies evaluated about 
the efficacy of  pregabalin  in reducing the preoperative 
anxiety and chronic pain[6-10].Hence we carried out a 
systematic review to present an updated meta-analysis 
of the  efficacy of pregabalin in relieving acute  
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postoperative pain and also to find out whether 
outcomes vary according to dose, frequency of 
administration of drug and or type of surgery.  
Database: The recommendations of the PRISMA 
statement were followed. We searched MEDLINE 
(1966–2014), the Cochrane Central Register of 
Controlled Trials (CENTRAL), EMBASE (1947–
2014) for randomized controlled trials (RCTs) that 
compared pregabalin with controls, in patients 
undergoing surgery.  
Data Search: Databases were searched using the term 
‘pregabalin’ combined with the MESH terms: ‘Pain, 
acute’, ‘Pain, postoperative’, ‘Postoperative period’,  
‘Pain, chronic’, and ‘Analgesics, opioid’.  
Inclusion criteria 
1. Studies where pregabalin was given prior to 
surgery and parameters like pain scores, opioid 
consumption, incidence of persistent pain were 
reported.   
2. Articles of all languages 
3. Reference articles in the retrieved studies 
Exclusion criteria  
1. Studies where pregabalin was given 
postoperatively 
2. Studies in which parameters were not reported 
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3. Studies in which controls/placebo was not 
included 
4. Reviews 
5. Abstracts 
6. Letters to the editor and  
7. Retrospective studies 
After collecting the articles the articles meeting the 
inclusion criteria were assessed separately by two 
authors using the risk of bias table suggested by the 
Cochrane Collaboration.
11
  
The main findings of our meta-analysis were pain 
scores at 2 and 24 hours, whereas the secondary 
findings were duration in post-anaesthesia care unit and 
hospital stay, incidence of persistent pain at 1, 3, 6, and 
12 months, preoperative anxiety scores, and side-
effects. 
Analyses were performed using the Review Manager 
(RevMan), Version 5.1, Copenhagen: The Nordic 
Cochrane Centre, The Cochrane Collaboration, 2011, 
and Comprehensive Meta-Analysis Software (version 
3.0). Meta-regression was performed using the method 
of moments. 
 
Results  
 
Out of 650 studies, 50 studies with 4012 patients (2212 
received pregabalin and 1800 served as control) were 
included in the final analysis. 45 studies investigated 
acute pain, and 5 chronic pain. The characteristics of 
the included studies are shown in Figure 1, Table 1.  
 
 
                     Fig 1: PRISMA flow chart detailing retrieved, excluded, assessed, and included trials 
 
Table 1:  Risk of bias table. Low, low risk of bias; high, high risk of bias; unclear, unclear risk of bias 
 
Reference Randomization 
sequence 
generation 
Allocation 
concealment  
Blinding of participants & 
personnel 
Blinding of 
outcome 
assessment 
Acin and 
colleagues  
Unclear  High  High  High 
Agarwal and 
colleagues  
Low Low Low Low 
Alimian and 
colleagues  
Unclear Low Low Low 
Balaban and 
colleagues 
Low Low Low Low 
Bekawi and 
colleagues 
Low Low Low Low 
Bornemann-
Cimenti and 
colleagues 
Low Low Low Low 
Buvanendran 
and colleagues 
Low Low Low Low 
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Discussion  
 
We found that the perioperative administration of 
pregabalin showed a statistically significant lowering 
in pain scores at rest, pain scores during movement and 
opioid consumption after surgery when compared with 
placebo. Opioid related side-effects i,e postoperative 
nausea and vomiting and pruritus were significantly 
lowered with pregabalin by 38% and 51%, 
respectively, relative to placebo after 24 hours of 
surgery. However there was a significantly higher 
incidence of sedation (46% increase), dizziness (33% 
increase), and visual disturbance (3.5 times more 
likely) relative to placebo.  The patients hospital stay 
was lessened by about 14 hours when compared with 
patients on placebo. Our findings regarding 
preoperative anxiety was that there was significantly 
lower anxiety with pregabalin. Regarding persistent 
pain, the benefits after 3 months was non conclusive, 
whereas at 6 and 12 months, there was little 
benefit[2,3]. 
The optimal dose or frequency of administration of 
pregabalin ranged from 50 to 300 mg. We found the 
drug dosage of 100 –150 and 300 mg but not ≤75 mg at 
2 hours after surgery, whereas at 24 hours, no 
statistically significant differences were detected 
between the three dose levels.  Overall, pregabalin 
showed opioid sparing of 25% at 24 hours. The impact 
on pain scores was less pronounced with 19% and 16% 
reduction in the mean pain scores at rest and on 
movement at 24 hours, and hence might not be 
clinically relevant. But there was a reduction in opioid-
related side-effects such as post operative nausea and 
vomiting and pruritus and at the same time increased 
risk of sedation and dizziness[5-8]. 
We could do only limited assessment of the impact of 
sedation on patients’ recovery. The duration of hospital 
stay was reduced with pregabalin administration, but 
this was only reported in five of the included studies[6-
10]. 
We found that the type of surgery and type of 
anaesthesia were significant predictors of some of the 
outcomes. The type of surgery was a significant 
predictor of pain scores at rest at 2 and 24 hours. This 
is in accordance with few earlier studies.
12 
The type of anaesthesia also predicted 2 hour pain 
scores on movement and 24 hour opioid consumption, 
likely due to the analgesic effect of regional 
anaesthesia in the early postoperative period.
13-16
 
 
Conclusion 
 
Perioperative pregabalin after surgery reduced pain 
scores, hospital stay, opiod side effects. We recomend 
future studies on a larger sample of studies with more 
parameters to accurately predict the efficacy of 
pregabalin in reducing postoperative acute persistant 
pain and other side effects. 
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